Jette, Belgium

Bernard Thienpont

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Katholieke Universiteit Leuven, Life Sciences Research Partners Vzw, Vib Vzw. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bernard Thienpont. Retrieved from https://idiyas.com/inventor/bernard-thienpont-idpld7mh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Bernard Thienpont: Innovator in Cancer Research

Introduction

Bernard Thienpont is a notable inventor based in Jette, Belgium. He has made significant contributions to the field of cancer research, particularly in understanding tumor hypoxia. His work has implications for improving cancer therapies and patient outcomes.

Latest Patents

Thienpont holds a patent titled "Markers for determining tumor hypoxia." This patent addresses the critical issue of hypoxic tumors, which are known to drive hypermethylation of tumor suppressor genes. The detection of this hypermethylation pattern in circulating tumor DNA serves as a surrogate marker for tumor hypoxia, allowing for the adaptation of therapy based on the tumor's condition. He has 1 patent to his name.

Career Highlights

Throughout his career, Thienpont has worked with various organizations, including Vib Vzw and Katholieke Universiteit Leuven, also known as KU Leuven R&D. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

One of his notable coworkers is Diether Lambrechts. Their collaboration has likely enhanced the research efforts in cancer treatment and diagnostics.

Conclusion

Bernard Thienpont's innovative work in cancer research, particularly regarding tumor hypoxia, showcases his commitment to advancing medical science. His contributions are vital for developing more effective cancer therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…